FdaApplication

NDA 216873

Back to search

Identifiers

Properties

PropertyValue
applicant_nameGLAXOSMITHKLINE LLC
application_typeNDA
approval_date2023-09-15

Products (3)

ProductActive ingredientStrengthDosage form
OJJAARAMOMELOTINIB DIHYDROCHLORIDEEQ 100MG BASETABLET;ORAL
OJJAARAMOMELOTINIB DIHYDROCHLORIDEEQ 200MG BASETABLET;ORAL
OJJAARAMOMELOTINIB DIHYDROCHLORIDEEQ 150MG BASETABLET;ORAL

3 products